Contraline
PrivateLast Round
Series B
Jun 2, 2026
Est. Valuation
$53.5M
Total Funding Raised
$114.22M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Contraline is a biotechnology company developing a long-lasting, non-hormonal, and reversible male contraceptive hydrogel.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Contraline Comparables
Compare Contraline with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Next Life Sciences | 91% | |
| VasDeBlock medical ApS | 79% | |
| Population Council | 72% | |
Contraline Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 2, 2026 | ||||
| Series A Extension | Nov 10, 2022 | ||||
| Series A | Oct 20, 2021 | ||||
| Grant | Nov 18, 2020 | ||||
| Grant | Jan 24, 2019 | ||||
Seed | Apr 18, 2017 |
Key People
Founding team and executive leadership
Contraline Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Male Contraceptive Initiative | Grant |
| RA Capital Management | Series B |
| GV | Series B, Series A Extension |
| Metaplanet Holdings | Series A, Series A Extension |
| Founders Fund | Series A, Seed |
| Invus Opportunities | Series B |
| Virginia Innovation Partnership Corporation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 17, 2026
Grew 15% QoQ, from 26 to 30 employees.
- Jun 22, 2026
Grew 25% QoQ, from 24 to 30 employees.
Contraline Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Contraline's valuation, stock price, and market status.